TY  - RPRT
TI  - EZH1/2 inhibition selectively targets SMARCA4/2 co-deficient lung cancer cells by suppressing stemness and proliferation.
AU  - Jeongjae Lee
AU  - Jaeik Oh
AU  - Soyeon Kim
AU  - Taekeun Park
AU  - Jeonghwan Youk
AU  - Miso Kim
AU  - Tae Min Kim
AU  - Dong-Wan Kim
AU  - Bhumsuk Keam
PY  - 2026
DO  - 10.1016/j.neo.2026.101349
UR  - https://pubmed.ncbi.nlm.nih.gov/42567102/
ID  - 42567102
ER  -